ArticleScientific reports2024

TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models.

Kayo Mitsukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.